Phosgene

Handbook of Toxicology of Chemical Warfare Agents

Volumn , Issue , 2009, Pages 321-330

  Bast, Cheryl B ^a   Glass, Dana F ^a  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951572855     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374484-5.00023-7     Document Type: Chapter

References (76)

1. ACGIH (American Conference of Governmental Industrial Hygienists) (2006). TLVS and BEIs Based on the Documentation of Threshold Limit Values for Chemical Substances and Physical Agents.
2. AIHA (American Industrial Hygiene Association) (2006). 2006 ERPG (Emergency Response Planning Guidelines) and Workplace Environmental Exposure Level Handbook. Fairfax, VA.
3. Amoore J.E., Hautala E. Odor as an aid to chemical safety: odor thresholds compared with threshold limit values and volatilities for 214 industrial chemicals in air and water dilution. J. Appl. Toxicol 1983, 3(6):272-290.
4. Beard R.R. Inorganic compounds of oxygen, nitrogen. carbon. In Patty's Industrial Hygiene and Toxicology 1982, Vol. 2C:4126-4128. John Wiley & Sons, New York. G.D. Clayton, F.E. Clayton (Eds.).
5. Borak J., Diller W.F. Phosgene exposure: mechanisms of injury and treatment strategies. J. Occup. Environ. Med 2001, 43:110-119.
6. Boyland E., McDonald F.F., Rumens M.J. The variation in the toxicity of phosgene for small animals with the duration of exposure. Br. J. Pharmacol 1946, 1:81-89.
7. Bradley B.L., Unger K.M. Phosgene inhalation: a case report. Texas Med 1982, 78:51-53.
8. Brown R.F.R., Jugg B.J., Harban F.M.J., Ashley Z., Kenward C.E., Platt J., Hill A., Rice P., Watkins P.E. Pathophysiological responses following phosgene exposure in the anesthetized pig. J. Appl. Toxicol 2002, 22:263-269.
9. Budavari, S., O'Neil, M.J., Smith, A., Heckelman, P.E. (1989). The Merck Index. Phosgene, p. 7314.
10. Burleson G.R., Keyes L.L. Natural killer activity in Fischer-344 rat lungs as a method to assess pulmonary immunocompetence: immunosuppression by phosgene inhalation. Immunopharmacol. Immunotoxicol 1989, 11(2&3):421-443.
11. Cameron G.R., Foss G.L. Porton Report No. 2316, serial no. 63. Effect of low concentrations of phosgene for 5 h on 5 consecutive days in groups of different animals 1941, British Embassy Defence Staff, Washington, DC.
12. Cameron, G.R., Courtice, F.C., Foss, G.L. (1942). Effect of exposing different animals to low concentrations of phosgene (1:5,000,000 = 0.9 mg/m3) for 5 hours on five consecutive days. Second report. In First report on phosgene poisoning: Chapter VIII. Washington DC: British Embassy Defence Staff; Porton Report No. 2349.
13. CRC Handbook of Chemistry and Physics B-82 1989, CRC Press, Florida, 1988-p. 69th edition. R.C. Weast, M.J. Astle, W.H. Beyer (Eds.).
14. Cordasco E.M., Demeter S.R., Kester L., Cordasco M.A., Lammert G., Beerel F. Pulmonary edema of environmental origin -newer concepts. Angiology 1986, 440-447. J. Vascul. Dis.
15. Currie, W.D., Hatch, G.E., Frosolono, M.F. (1987a). Pulmonary alterations in rats due to acute phosgene inhalation. Fundam. Appl. Toxicol. 8: 107-14.
16. Currie, W.D., Hatch, G.E., Frosolono, M.F. (1987b). Changes in lung ATP concentration in the rat after low-level phosgene exposure. J. Biochem. Toxicol. 2(1-76): 105-13.
17. Delephine S. Summary notes on two fatalities due to inhaling phosgene. J. Ind. Hyg 1922, 4:433-440.
18. Deutsche Forschungsgemeinschaft MAK (Maximale Arbeitsplatzkonzentration -Maximum workplace concentration). List of MAK and BAT Values 2006, 101. Report No. 42.
19. Diller W.F. Medical phosgene problems and their possible solution. J. Occup. Med 1978, 20:189-193.
20. Diller W.F. Pathogenesis of phosgene poisoning. Toxicol. Ind. Health 1985, 1(2):7-13.
21. Diller W.F., Zante R. Dosis-wirkungs-beziehungen bei phosgen-einwirkung auf mensch und tier. Zbl. Arbeitsmed 1982, 32:360-368.
22. Diller W.F., Schnellbaecher F., Wuestefeld E. Late pulmonary sequelae of phosgene poisoning or inhalation -toxic pulmonary edema. Arbeitsmed. Arbeitsschultz Prophyl 1979, 29:5-16.
23. Dunlap, K.L. (2001). Phosgene. Kirk-Othmer Encyclopedia of Chemical Technology. (Online at). http://www.mrw.interscience.wiley.com.
24. Ehrlich J.P., Gunnison A.E., Burleson G.R. Influenza virus-specific cytotoxic T-lymphocyte activity in Fischer 344 rat lungs as a method to assess pulmonary immunocompetence: effect of phosgene inhalation. Inhal. Toxicol 1989, 1:129-138.
25. Everett D., Overholt E.L. Phosgene poisoning. JAMA 1968, 205(4):243-245.
26. Franch S., Hatch G.E. Pulmonary biochemical effects of inhaled phosgene in rats. J. Toxicol. Environ. Health 1986, 19:413-423.
27. Frosolono M.F., Currie W.D. Response of the pulmonary surfactant system to phosgene. Toxicol. Ind. Health 1985, 1(2):29-35.
28. Galdston, M., Leutscher, J.A., Longcope, W.T. et. al. (1947a). A study of the residual effects of phosgene poisoning in human subjects: I. After acute exposure. J. Clin. Invest.26: 145-68.
29. Galdston, M., Leutscher, J.A., Longcope, W.T., Ballich, N.L. (1947b). A study of the residual effects of phosgene poisoning in human subjects: II. After chronic exposure. J. Clin. Invest.26: 169-81.
30. Gross P., Rinehart W.E., Hatch T. Chronic pneumonitis caused by phosgene: an experimental study. Arch. Environ. Health 1965, 10:768-775.
31. Haber F.R. Zur geschichte des gaskrieges [On the history of the gas war]. Fuenf Vortraege aus den Jahren 1920-23 [Five Lectures from the Years 1920-1923] 1924, Verlag von Julius Springer, Berlin, pp. 76-92.
32. Hatch G.E., Slade R., Stead A.G., Graham J.A. Species comparison of acute inhalation toxicity of ozone and phosgene. J. Toxicol. Environ. Health 1986, 19:43-53.
33. Hegler C. On the mass poisoning by phosgene in Hamburg. I. Clin. Observ 1928, 54:1551-1553.
34. Henschler, D. (1971). German MAK criteria. (From Ehrlicher, H. (1971). Personal Communication, Department of Medicine, Bayer AG, Leverkusen.
35. Herzog H., Pletscher A. Die wirkung von industriellen reizgasen auf die bronchialschleimhaut des menschen. Schweiz. Med. Wochenschr 1955, 85:477-481.
36. Illing J.W., Mole M.L., Graham J.A., Williams T.B., Ménache M., Gardner D.E. Influence of phosgene inhalation on extrapulmonary effects in mice. Inhal. Toxicol 1988, 1:13-20.
37. Jaskot R.H., Grose E.C., Stead A.G. Increase in angiotensin-converting enzyme in rat lungs following inhalation of phosgene. Inhal. Toxicol 1989, 1:71-78.
38. Jaskot R.H., Grose E.C., Richards J.H., Doerfler D.L. Effects of inhaled phosgene on rat lung antioxidant systems. Fundam. Appl. Toxicol 1991, 17:666-674.
39. Kaerkes B. Experiences with a phosgene indicator badge during an eleven-year period. M.D. Dissertation 1992, Heinrich-Heine University, Duesseldorf, Germany.
40. Kawai M. Inhalation toxicity of phosgene and chloropicrin. J. Sangyo Igaku 1973, 15:406-407.
41. Keeler, J.R., Hurt, H.H., Nold, J.B., Lennox, W.J. (1990a). Estimation of the LCt50 of phosgene in sheep. Drug Chem. Toxicol. 13(2&3): 229-39.
42. Keeler, J.R., Hurt, H.H., Nold, J.B., Corcoran, K.D., Tezak-Reid, T.M. (1990b). Phosgene-induced lung injury in sheep. Inhal. Toxicol. 2: 391-406.
43. Kodavanti U.P., Costa D.L., Giri S.N., Starcher B., Hatch G.E. Pulmonary structural and extracellular matrix alterations in Fischer 344 rats following subchronic exposure. Fundam. Appl. Toxicol 1997, 37:54-63.
44. Leonardos G., Kendall D.A., Barnard N.J. Odor threshold determinations of 53 odorant chemicals. Presented at the 61th Annual Meeting of the Air Pollution Control Association 1968, St Paul, MNJune 2327.
45. Lipsett M.J., Shusterman D.J., Beard R.R. Industrial Hygiene and Toxicology. Phosgene 1994, Vol. II:4557-4563. Wiley & Sons, New York, J. 4th edition. F. part, G.D. Clayton, F.E. Clayton (Eds.).
46. Marrs T.C., Maynard R.L., Sidell F.R. Chemical Warfare Agents: Toxicology and Treatment 1996, John Wiley and Sons, New York.
47. Ministry of Defense Medical Manual of Defence against Chemical Agents. Ministry of Defence D/Med(F&S) (2)/10/1/1 1987, HMSO, London.
48. Misra N.P., Manoria P.C., Saxena K. Fatal pulmonary oedema with phosgene poisoning. J. Assoc. Physicians. India 1985, 33(6):430-431.
49. NIOSH (National Institute of Occupational Safety and Health) (1976). Criteria for a recommended standard: occupational exposure to phosgene. NIOSH-76-137.
50. NIOSH (National Institute of Occupational Safety and Health) (2005). Phosgene. NIOSH Pocket Guide to Chemical Hazards. (Online at). http://www.cdc.gov/niosh/npg/ngpd0504.html.
51. NRC (National Research Council) Emergency and Continuous Exposure Limits for Selected Airborne Contaminants 1985, National Academy Press, Washington DC, Phosgenepp. 69-86.
52. NRC (National Research Council) (2002). Acute Exposure Guideline Levels for Selected Airborne Chemicals, Vol. 2, Phosgene, pp. 15-70. National Academy Press, Washington DC.
53. Pauluhn, J. (2006a). Acute nose-only exposure of rats to phosgene. Part I. Concentration 1 time dependence of LC50s, non-lethal-threshold concentrations and analysis of breathing patterns. Inhal. Toxicol. 18: 423-35.
54. Pauluhn, J. (2006b). Acute nose-only exposure of rats to phosgene. Part II. Concentration 1 time dependence of changes in bronchoalveolar lavage during a follow-up period of 3 months. Inhal. Toxicol. 18: 595-607.
55. Pauluhn, J. (2006c). Acute head-only exposure of dogs to phosgene. Part III. Comparison of indicators of lung injury in dogs and rats. Inhal. Toxicol. 18: 609-21.
56. Pauluhn J., Carsom A., Costa D.L., Gordon T., Kodavanti U., Last J.A., Matthay M.A., Pinkerton K.E., Sciuto A.M. Workshop summary: phosgene-induced pulmonary toxicity revisited: appraisal of early and late markers of pulmonary injury from animal models with emphasis on human significance. Inhal. Toxicol 2007, 19:789-810.
57. Polednak A.P. Mortality among men occupationally exposed to phosgene in 1943-1945. Environ. Res. 1980, 22:357-367.
58. Polednak A.P., Hollis D.R. Mortality and causes of death among workers exposed to phosgene in 1943-45. Toxicol. Ind. Health 1985, 1(2):137-147.
59. Regan R.A. Review of clinical experience in handling phosgene exposure cases. Toxicol. Ind. Health 1985, 1(2):69-71.
60. Rinehart W.E., Hatch T. Concentration-time product (CT) as an expression of dose in sublethal exposures to phosgene. Ind. Hyg. J. November/December 1964, 545-553.
61. Sandall T.E. The later effects of gas poisoning. Lancet 1922, 203:857-859.
62. Sciuto A.M. Assessment of early acute lung injury in rodents exposed to phosgene. Arch. Toxicol 1998, 72:283-288.
63. Sciuto A.M., Moran T.S., Narula A., Forster J.S. Disruption of gas exchange in mice after exposure to the chemical threat agent phosgene. Mil. Med 2001, 166(9):809-814.
64. SDU Uitgevers (2000). Nationale MAC List. The Hague (under the auspices of the Ministry of Social Affairs and Employment). The Netherlands.
65. Selgrade M.K., Starnes D.M., Illing J.W., Daniels M.J., Graham J.A. Effects of phosgene exposure on bacterial, viral and neoplastic lung disease susceptibility in mice. Inhal. Toxicol 1989, 1:243-259.
66. Selgrade, M.K., Gilmour, M.I., Yang, Y.G., G.R. Burleson, G.R., Hatch, G.E. (1995). Pulmonary host defenses and resistance to infection following subchronic exposure to phosgene. Inhal. Toxicol.7: 1257-68.
67. Sidell, F.R., Takafuji, E.T., Franz, D.R. (eds) (1997). Medical aspects of chemical and biological warfare. Part 1. Textbook of Military Medicine, pp. 118-19 and 257-60. TMM Publications, Borden Institute, Washington DC.
68. Slade R., Highfill J.W., Hatch G.E. Effects of depletion of ascorbic acid or nonprotein sulfhydryls on the acute inhalation toxicity of nitrogen dioxide, ozone and phosgene. Inhal. Toxicol 1989, 1:261-271.
69. Stavrakis P. The use of hexamethylenetetramine (HMT) in treatment of acute phosgene poisoning. Ind. Med 1971, 40:30-31.
70. TEMIS (Trauma Emergency Medical Information System) (1997). Phosgene.
71. Underhill F.P. The Lethal War Gases: Physiology and Experimental Treatment 1920, Yale University Press, New Haven, CT.
72. US EPA (1986). Health Assessment Document for Phosgene. Office of Health and Environmental Assessment. EPA/600/8-86/022A.
73. US EPA (US Environmental Protection Agency) (2003). Phosgene: USEPA HPV challenge program test plan submission. EPA/201-14578A. Washington DC.
74. US EPA (US Environmental Protection Agency) (2005). Toxicological review of phosgene: in support of summary information on the integrated risk information system (IRIS). EPA/635/R-06/001. Washington DC.
75. Wells B.A. Phosgene: a practitioner's viewpoint. Toxicol. Ind. Health 1985, 1(2):81-92.
76. 50 values. Inhal. Toxicol 1990, 2:105-117.